Sodium glucose cotransporter (SGLT)‐2 inhibitors: Do we need them for glucose‐lowering, for cardiorenal protection or both? von Scholtes, Rosalie A., Baar, Michaël J. B., Lytvyn, Yuliya, Bjornstad, Petter, Nieuwdorp, Max, Cherney, David Z. I., Raalte, Daniël H.

Volltext

The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists von van Baar, Michaël J. B., van der Aart, Annemarie B., Hoogenberg, Klaas, Joles, Jaap A., Heerspink, Hiddo J. L., van Raalte, Daniël H.

Volltext

Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors von Scholtes, Rosalie A., Baar, Michaël J. B., Kok, Megan D., Bjornstad, Petter, Cherney, David Z. I., Joles, Jaap A., Raalte, Daniël H.

Volltext

SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management von van Baar, Michaël J B, van Ruiten, Charlotte C, Muskiet, Marcel H A, van Bloemendaal, Liselotte, IJzerman, Richard G, van Raalte, Daniël H

Volltext

Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT... von Scholtes, Rosalie A., Muskiet, Marcel H. A., van Baar, Michiel J. B., Hesp, Anne C., Greasley, Peter J., Karlsson, Cecilia, Hammarstedt, Ann, Arya, Niki, van Raalte, Daniel H., Heerspink, Hiddo J. L.

Volltext

Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function von van Bommel, Erik J. M., Ruiter, Danique, Muskiet, Marcel H. A., van Baar, Michael J. B., Kramer, Mark H. H., Nieuwdorp, Max, Joles, Jaap A., Bjornstad, Petter, van Raalte, Daniel H.

Volltext

GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes von Muskiet, Marcel H. A., Tonneijck, Lennart, Smits, Mark M., van Baar, Michaël J.B., Kramer, Mark H. H., Hoorn, Ewout J., Joles, Jaap A., van Raalte, Daniël H.

Volltext

Characterisation of bacteria by matrix-assisted laser desorption/ionisation and electrospray mass spectrometry von van Baar, Ben L.M.

Volltext

Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity von van Baar, Michaël J.B., van Bommel, Erik J.M., Smits, Mark M., Touw, Daan J., Nieuwdorp, Max, ten Kate, Reinier W., Joles, Jaap A., van Raalte, Daniël H.

Volltext

The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated pat... von van Bommel, Erik J.M., Muskiet, Marcel H.A., van Baar, Michaël J.B., Tonneijck, Lennart, Smits, Mark M., Emanuel, Anna L., Bozovic, Andrea, Danser, A.H. Jan, Geurts, Frank, Hoorn, Ewout J., Touw, Daan J., Larsen, Emil L., Poulsen, Henrik E., Kramer, Mark H.H., Nieuwdorp, Max, Joles, Jaap A., van Raalte, Daniël H.

Volltext

Application of matrix-assisted laser desorption/ionization to on-line aerosol time-of-flight mass spectrometry von Stowers, M. A., van Wuijckhuijse, A. L., Marijnissen, J. C. M., Scarlett, B., van Baar, B. L. M., Kientz, Ch. E.

Volltext

SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function von Suijk, Danii L S, van Baar, Michaël J B, van Bommel, Erik J M, Iqbal, Zainab, Krebber, Merle M, Vallon, Volker, Touw, Daan, Hoorn, Ewout J, Nieuwdorp, Max, Kramer, Mark M H, Joles, Jaap A, Bjornstad, Petter, van Raalte, Daniël H

Volltext

SGLT2 inhibitors’ interaction with other renoactive drugs in type 2 diabetes patients: still a lot to learn von van Baar, Michaël J.B., Scholtes, Rosalie A., van Raalte, Daniël H.

Volltext

Determination of microcontaminants in sediments by on-line solid-phase extraction–gas chromatography–mass spectrometry von Slobodnı́k, Jaroslav, Ramalho, Sı́lvia, van Baar, Ben L.M, Louter, Arjan J.H, Brinkman, Udo A.Th

Volltext

Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543-1556 von van Baar, Michaël J B, van Ruiten, Charlotte C, Muskiet, Marcel H A, van Bloemendaal, Liselotte, IJzerman, Richard G, van Raalte, Daniël H

Volltext

The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet... von Scholtes, Rosalie A., Muskiet, Marcel H.A., van Baar, Michiel J.B., Hesp, Anne C., Greasley, Peter J., Hammarstedt, Ann, Karlsson, Cecilia, Hallow, Karen M., Danser, A.H. Jan, Heerspink, Hiddo J.L., van Raalte, Daniël H.

Volltext

GLP-1 receptor agonists, CKD, and eGFR trajectory von van Baar, Michaël J B, van Raalte, Daniël H, Muskiet, Marcel H A

Volltext

Acute Effects of Insulin Infusion on Kidney Hemodynamic Function in People With Type 2 Diabetes and Normal Kidney Function von van Baar, Michaël J.B., van Bommel, Erik J.M., Touw, Daan J., Nieuwdorp, Max, Joles, Jaap A., Krebber, Merle M., Bjornstad, Petter, van Raalte, Daniël H.

Volltext

Renal outcomes in CVOTs: keep calm and carry on von Muskiet, Marcel H A, van Baar, Michaël J B, Scholtes, Rosalie A, van Raalte, Daniël H

Volltext

Digital forensics as a service: Game on von van Beek, H.M.A., van Eijk, E.J., van Baar, R.B., Ugen, M., Bodde, J.N.C., Siemelink, A.J.

Volltext